Transdermal Testosterone market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Testosterone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Transdermal Testosterone market is segmented into
Gel
Patch
Segment by Application, the Transdermal Testosterone market is segmented into
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Regional and Country-level Analysis
The Transdermal Testosterone market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transdermal Testosterone market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transdermal Testosterone Market Share Analysis
Transdermal Testosterone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Testosterone business, the date to enter into the Transdermal Testosterone market, Transdermal Testosterone product introduction, recent developments, etc.
The major vendors covered:
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
1 Study Coverage
1.1 Transdermal Testosterone Product Introduction
1.2 Market Segments
1.3 Key Transdermal Testosterone Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transdermal Testosterone Market Size Growth Rate by Type
1.4.2 Gel
1.4.3 Patch
1.5 Market by Application
1.5.1 Global Transdermal Testosterone Market Size Growth Rate by Application
1.5.2 Primary Hypogonadism
1.5.3 Hypogonadotropic Hypogonadism
1.5.4 Late-Onset Hypogonadism
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Transdermal Testosterone Market Size, Estimates and Forecasts
2.1.1 Global Transdermal Testosterone Revenue 2015-2026
2.1.2 Global Transdermal Testosterone Sales 2015-2026
2.2 Global Transdermal Testosterone, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Transdermal Testosterone Historical Market Size by Region (2015-2020)
2.3.1 Global Transdermal Testosterone Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Transdermal Testosterone Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Transdermal Testosterone Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Transdermal Testosterone Sales Forecast by Region (2021-2026)
2.4.2 Global Transdermal Testosterone Revenue Forecast by Region (2021-2026)
3 Global Transdermal Testosterone Competitor Landscape by Players
3.1 Global Top Transdermal Testosterone Sales by Manufacturers
3.1.1 Global Transdermal Testosterone Sales by Manufacturers (2015-2020)
3.1.2 Global Transdermal Testosterone Sales Market Share by Manufacturers (2015-2020)
3.2 Global Transdermal Testosterone Manufacturers by Revenue
3.2.1 Global Transdermal Testosterone Revenue by Manufacturers (2015-2020)
3.2.2 Global Transdermal Testosterone Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transdermal Testosterone Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transdermal Testosterone Revenue in 2019
3.2.5 Global Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Transdermal Testosterone Price by Manufacturers
3.4 Global Transdermal Testosterone Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Testosterone Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Testosterone Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Testosterone Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Transdermal Testosterone Market Size by Type (2015-2020)
4.1.1 Global Transdermal Testosterone Sales by Type (2015-2020)
4.1.2 Global Transdermal Testosterone Revenue by Type (2015-2020)
4.1.3 Transdermal Testosterone Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transdermal Testosterone Market Size Forecast by Type (2021-2026)
4.2.1 Global Transdermal Testosterone Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Testosterone Revenue Forecast by Type (2021-2026)
4.2.3 Transdermal Testosterone Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transdermal Testosterone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Transdermal Testosterone Market Size by Application (2015-2020)
5.1.1 Global Transdermal Testosterone Sales by Application (2015-2020)
5.1.2 Global Transdermal Testosterone Revenue by Application (2015-2020)
5.1.3 Transdermal Testosterone Price by Application (2015-2020)
5.2 Transdermal Testosterone Market Size Forecast by Application (2021-2026)
5.2.1 Global Transdermal Testosterone Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Testosterone Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Testosterone Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Transdermal Testosterone Market Size YoY Growth 2015-2026
6.1.1 United States Transdermal Testosterone Sales YoY Growth 2015-2026
6.1.2 United States Transdermal Testosterone Revenue YoY Growth 2015-2026
6.1.3 United States Transdermal Testosterone Market Share in Global Market 2015-2026
6.2 United States Transdermal Testosterone Market Size by Players (International and Local Players)
6.2.1 United States Top Transdermal Testosterone Players by Sales (2015-2020)
6.2.2 United States Top Transdermal Testosterone Players by Revenue (2015-2020)
6.3 United States Transdermal Testosterone Historic Market Review by Type (2015-2020)
6.3.1 United States Transdermal Testosterone Sales Market Share by Type (2015-2020)
6.3.2 United States Transdermal Testosterone Revenue Market Share by Type (2015-2020)
6.3.3 United States Transdermal Testosterone Price by Type (2015-2020)
6.4 United States Transdermal Testosterone Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Transdermal Testosterone Sales Forecast by Type (2021-2026)
6.4.2 United States Transdermal Testosterone Revenue Forecast by Type (2021-2026)
6.4.3 United States Transdermal Testosterone Price Forecast by Type (2021-2026)
6.5 United States Transdermal Testosterone Historic Market Review by Application (2015-2020)
6.5.1 United States Transdermal Testosterone Sales Market Share by Application (2015-2020)
6.5.2 United States Transdermal Testosterone Revenue Market Share by Application (2015-2020)
6.5.3 United States Transdermal Testosterone Price by Application (2015-2020)
6.6 United States Transdermal Testosterone Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Transdermal Testosterone Sales Forecast by Application (2021-2026)
6.6.2 United States Transdermal Testosterone Revenue Forecast by Application (2021-2026)
6.6.3 United States Transdermal Testosterone Price Forecast by Application (2021-2026)
7 North America
7.1 North America Transdermal Testosterone Market Size YoY Growth 2015-2026
7.2 North America Transdermal Testosterone Market Facts & Figures by Country
7.2.1 North America Transdermal Testosterone Sales by Country (2015-2020)
7.2.2 North America Transdermal Testosterone Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Transdermal Testosterone Market Size YoY Growth 2015-2026
8.2 Europe Transdermal Testosterone Market Facts & Figures by Country
8.2.1 Europe Transdermal Testosterone Sales by Country
8.2.2 Europe Transdermal Testosterone Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Transdermal Testosterone Market Size YoY Growth 2015-2026
9.2 Asia Pacific Transdermal Testosterone Market Facts & Figures by Country
9.2.1 Asia Pacific Transdermal Testosterone Sales by Region (2015-2020)
9.2.2 Asia Pacific Transdermal Testosterone Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Transdermal Testosterone Market Size YoY Growth 2015-2026
10.2 Latin America Transdermal Testosterone Market Facts & Figures by Country
10.2.1 Latin America Transdermal Testosterone Sales by Country
10.2.2 Latin America Transdermal Testosterone Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Transdermal Testosterone Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Transdermal Testosterone Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Testosterone Sales by Country
11.2.2 Middle East and Africa Transdermal Testosterone Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AbbVie
12.1.1 AbbVie Corporation Information
12.1.2 AbbVie Description and Business Overview
12.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Transdermal Testosterone Products Offered
12.1.5 AbbVie Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Transdermal Testosterone Products Offered
12.2.5 Teva Recent Development
12.3 Perrigo
12.3.1 Perrigo Corporation Information
12.3.2 Perrigo Description and Business Overview
12.3.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Perrigo Transdermal Testosterone Products Offered
12.3.5 Perrigo Recent Development
12.4 Endo Pharmaceuticals
12.4.1 Endo Pharmaceuticals Corporation Information
12.4.2 Endo Pharmaceuticals Description and Business Overview
12.4.3 Endo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Endo Pharmaceuticals Transdermal Testosterone Products Offered
12.4.5 Endo Pharmaceuticals Recent Development
12.5 Acerus Pharmaceuticals
12.5.1 Acerus Pharmaceuticals Corporation Information
12.5.2 Acerus Pharmaceuticals Description and Business Overview
12.5.3 Acerus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Acerus Pharmaceuticals Transdermal Testosterone Products Offered
12.5.5 Acerus Pharmaceuticals Recent Development
12.6 Lupin
12.6.1 Lupin Corporation Information
12.6.2 Lupin Description and Business Overview
12.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lupin Transdermal Testosterone Products Offered
12.6.5 Lupin Recent Development
12.7 Dr. Reddy's Laboratories
12.7.1 Dr. Reddy's Laboratories Corporation Information
12.7.2 Dr. Reddy's Laboratories Description and Business Overview
12.7.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Products Offered
12.7.5 Dr. Reddy's Laboratories Recent Development
12.8 Upsher-Smith Laboratories
12.8.1 Upsher-Smith Laboratories Corporation Information
12.8.2 Upsher-Smith Laboratories Description and Business Overview
12.8.3 Upsher-Smith Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Upsher-Smith Laboratories Transdermal Testosterone Products Offered
12.8.5 Upsher-Smith Laboratories Recent Development
12.9 Allergan
12.9.1 Allergan Corporation Information
12.9.2 Allergan Description and Business Overview
12.9.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Allergan Transdermal Testosterone Products Offered
12.9.5 Allergan Recent Development
12.10 Cipla Inc.
12.10.1 Cipla Inc. Corporation Information
12.10.2 Cipla Inc. Description and Business Overview
12.10.3 Cipla Inc. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Cipla Inc. Transdermal Testosterone Products Offered
12.10.5 Cipla Inc. Recent Development
12.11 AbbVie
12.11.1 AbbVie Corporation Information
12.11.2 AbbVie Description and Business Overview
12.11.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AbbVie Transdermal Testosterone Products Offered
12.11.5 AbbVie Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Transdermal Testosterone Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Testosterone Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
*If Applicable.